Mr. MS Zama
Chief Executive Officer
Chief Executive Officer - CEO
MS Zama, the Chief Executive Officer (CEO) / Head of Operations of Century Pharma, he is a MBA graduate in business administration and brings over 15 years of leadership experience in Pharmaceuticals, Health care, Asset Management, R&D, Finance and Business Consultation. With strong background in strategic growth, drug development and innovation, he is committed to evolving patient care through cutting-edge research and the sustainable business practices.
Under his leadership the company continues to magnify its global footprint, reinforce R & D capabilities and can deliver high-quality and affordable medicines.
Mr. V V S Suresh
Managing Director
Managing Director - MD
Mr. V V S Suresh, as Director of the company is taking care of day today operations of the company ensuring smooth work flow of the company. He is a B.Tech graduate and worked in Singapore for 18 years as Regional EHS Director managing EHS operations in South East Asia for CH2M HILL company based in Denver, Colarado.
He received various awards from Ministry of Manpower, Ministry of Environment, Singapore. Also received OCEO Award (Office of the Chief Executive Officer award) from the CEO (Mr. Ralph Peterson) of CH2MHILL from USA.
Dr. Sudheer Kushwaha
Director for Research and Development
Director for Research and Development
Dr. Sudheer Kushwaha serves as Director Research and Development at Century Pharma and he serves as the Medical Director of Cardiac Transplant and Director of The Mechanical Circulatory Support Program at the Mayo Clinic USA, Rochester, Minnesota. Dr. Sudheer Kushwaha is a world-renowned specialist in the field of circulatory failure, cardiac transplantation and mechanical circulatory support with over 25 years of experience. He has been involved in this field since the development of the first mechanical circulatory devices and therefore has a depth of knowledge and experience, which is applied directly to patient care.
He has published extensively with several landmark papers in leading peer-reviewed journals such as Circulation, JACC and Journal of Heart and Lung Transplantation. His publications and abstracts number over 200 and he has presented in the US and internationally at over 100 Cardiology and Heart Failure conferences. Dr. Sudheer Kushwaha trained at Harefield Hospital, UK before going on to further training and research at the Massachusetts General Hospital, Harvard Medical School. He has held faculty appointments at Mount Sinai Medical Center and University of North Carolina before joining Mayo Clinic in 2000. Dr. Sudheer Kushwaha is the primary named inventor of the MI-VADTM device.
Dr. Seeram Ramakrishna
Chief Scientific Advisor
Chief Scientific Advisor
Academician Seeram Ramakrishna is a world-renowned professor at the National University of Singapore (NUS), which is ranked among the top three universities in the world for interdisciplinary research. He is among the top four scientists of Singapore (https://top2percentscientists.com/top-10-scientists-in-singapore-2024/). He is named among the World’s Most Influential Minds (Thomson Reuters) and a Highly Ranked Scholar (Scholar GPS) with more than 800 Q1 journals papers with 216 H-Index and about 2,19,359 citations. His contributions also appeared in journals such Nature, Nature Reviews Methods, Nature Communications, Matter, so on. Highest professional distinctions include Fellow | Foreign Academician of Chinese Academy of Engineering; UK Royal Academy of Engineering (FREng); Singapore Academy of Engineering; Indian National Academy of Engineering; ASEAN Academy of Engineering & Technology; International Academy of Engineering and Technology; and International Academy of Bionic Science
He is also an elected Fellow of AAAS, ASM International, ASME, AIMBE, USA; IMechE and IoM3, UK; ISTE, India; and IUBSE (FBSE). He received a PhD from the University of Cambridge, UK, and TGMP from Harvard University, USA. He received advanced research experiences from MIT and Johns Hopkins University, USA and KIT, Japan. He is a Chair Professor of Tsinghua University and Xinghua Distinguished Chair Professor, China; Distinguished Professor of IIT Hyderabad, India; and Everest Chair of MBUST, Nepal. Out of three decades of working at the National University of Singapore (NUS), about 15 years of senior academic leadership includes NUS Vice-President (Research Strategy); Dean of NUS Faculty of Engineering; Director of NUS Enterprise; Director of NUS Industry and Technology Relations Office (INTRO); Director of NUS International Relations Office (IRO); Chairman of Solar Energy Institute of Singapore (SERIS); Director of NUS Bioengineering Initiative; and Director of NUS Nanoscience & Nanotechnology Initiative (NUSNNI).
Jahnavi Sai Vallamkonda
Director
Director
Regulatory Comploance Specialist at Murata Vios,Inc / Georgia Tech MBID’24 Project Management, Financial Planning for R&D projects, Technology Strategy Management, Additive Manufacturing & Rapid prototyping, Medical Robotics, Human-Centered Design, Quality and Regulatory Strategy, Medical devices manufacturing, Design History File(DHF), Documentation, Quality Management Systems(QMS) Lean Six Sigma